It has previously been shown that cancer cell lines including osteosarcoma, lung cancer and glioma stem cell lines that rely on the ALT pathway were hypersensitive to the inhibition of the protein kinase ataxia telangiectasia- and RAD3-related protein (ATR) [41]. This evidence concerns the gene ATR and cancer.